The Westaim Corporation is a private equity firm specializing in direct and indirect investments through acquisitions, joint ventures, secondary investments both direct and indirect, fund of fund investments, and other arrangements. For direct investments, the firm invests in early venture, mid venture, late venture, middle market, later stage, mature, emerging growth, PIPEs, and buyout transactions. For fund of fund investments, it seeks to invest in private equity funds, venture capital funds, and hedge funds. The firm seeks to provide long term capital to businesses operating in the global financial services industry. It typically acquires controlling interests in businesses. The firm seeks to acquire debt, equity, or derivative securities of both public and private companies. It invests with the objective of providing its shareholders with capital appreciation and real wealth preservation. The firm seeks to provide its portfolio companies with advisory services including, but not limited to, advice on capital allocation, financing strategy, performance measurement and merger and acquisition support. It also seeks to partner with like-minded providers of third party capital to help supplement the firm's own capital, when completing acquisitions. The firm generally seeks to hold its investments for seven to 15 years. The Westaim Corporation was founded in 1996 and is based in Toronto, Canada.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorBasic Materials
Phone416-969-3333
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$4.50 million
Profitability
Miscellaneous
Employees8
Next Earnings Date3/25/2020 (Estimated)
OptionableNot Optionable
Westaim (OTCMKTS:WEDXF) Frequently Asked Questions
What is Westaim's stock symbol?
Westaim trades on the OTCMKTS under the ticker symbol "WEDXF."
When is Westaim's next earnings date?
Has Westaim been receiving favorable news coverage?
Media headlines about WEDXF stock have trended very negative recently, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Westaim earned a news sentiment score of -3.3 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Westaim.
Who are some of Westaim's key competitors?
Some companies that are related to Westaim include Luminex (LMNX), Cryolife (CRY), Axonics Modulation Technologies (AXNX), Intersect ENT (XENT), Orthofix Medical (OFIX), Cerus (CERS), MiMedx Group (MDXG), Orthopediatrics (KIDS), LeMaitre Vascular (LMAT), Anika Therapeutics (ANIK), Antares Pharma (ATRS), SurModics (SRDX), SI-Bone (SIBN), AngioDynamics (ANGO) and Alphatec (ATEC).
What other stocks do shareholders of Westaim own?
Who are Westaim's key executives?
Westaim's management team includes the folowing people:
- Mr. Ian W. Delaney, Exec. Chairman (Age 75)
- Mr. John Cameron MacDonald CFA, Pres, CEO & Director
- Mr. Glenn Garry MacNeil CFA, CPA, Chief Financial Officer (Age 60)
- Mr. Robert Terrance Kittel CFA, CPA, Chief Operating Officer (Age 47)
- Mr. Joseph Arthur Schenk, Managing Director (Age 60)
How do I buy shares of Westaim?
Shares of WEDXF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Westaim's stock price today?
One share of WEDXF stock can currently be purchased for approximately $1.88.
How big of a company is Westaim?
What is Westaim's official website?
How can I contact Westaim?
Westaim's mailing address is 70 York Street Suite 1700, Toronto A6, M5J 1S9. The company can be reached via phone at 416-969-3333 or via email at [email protected]
MarketBeat Community Rating for Westaim (OTCMKTS WEDXF)
MarketBeat's community ratings are surveys of what our community members think about Westaim and other stocks. Vote "Outperform" if you believe WEDXF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WEDXF will underperform the S&P 500 over the long term. You may vote once every thirty days.
